Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells
暂无分享,去创建一个
Maheshkumar S. Pandit | Jae-Hoon Chang | Hyun-Jeong Ko | Ben Kang | Jae-Hee Ahn | Yun‐Seo Kil | M. Jeong | Y. Ouh | Ye Gu | Ram Hari Pokhrel | Joo-Won Nam | Sunil Mishra | Youngjoo Han | Jong-Oh Kim | Sunil S Mishra
[1] N. Pavlova,et al. The hallmarks of cancer metabolism: Still emerging. , 2022, Cell metabolism.
[2] P. Oefner,et al. Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo , 2021, EBioMedicine.
[3] Jae-Hoon Chang,et al. AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway , 2021, Molecular cancer.
[4] Jae-Hoon Chang,et al. LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1 , 2021, Journal of Molecular Medicine.
[5] Yangzhe Wu,et al. Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications , 2021, Frontiers in Immunology.
[6] Jae-Hoon Chang,et al. Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL‐2 expression to ameliorate DSS‐induced colitis , 2021, European journal of immunology.
[7] Gen Li,et al. Asparagine enhances LCK signalling to potentiate CD8+ T-cell activation and anti-tumour responses , 2021, Nature Cell Biology.
[8] P. Rochaix,et al. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells , 2020, JCI insight.
[9] Z. Cai,et al. Simultaneous determination of methionine cycle metabolites, urea cycle intermediates and polyamines in serum, urine and intestinal tissue by using UHPLC-MS/MS. , 2020, Talanta.
[10] Hyunjin Jeong,et al. A Novel Anti-PD-L1 Antibody Exhibits Antitumor Effects on Multiple Myeloma in Murine Models via Antibody-Dependent Cellular Cytotoxicity , 2020, Biomolecules & therapeutics.
[11] W. Zou,et al. Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy. , 2020, Molecular cell.
[12] Sun-Young Chang,et al. Plasmacytoid dendritic cells regulate colitis-associated tumorigenesis by controlling myeloid-derived suppressor cell infiltration. , 2020, Cancer letters.
[13] Y. Zhuang,et al. PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer , 2020, Journal for ImmunoTherapy of Cancer.
[14] A. Chinnaiyan,et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation , 2020, Nature.
[15] E. Richardson,et al. Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms , 2020, Cancer Gene Therapy.
[16] M. Lenardo,et al. A guide to cancer immunotherapy: from T cell basic science to clinical practice , 2020, Nature Reviews Immunology.
[17] Maxim N. Artyomov,et al. Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming. , 2020, Cell metabolism.
[18] Meenakshi S Kagda,et al. New developments on the Encyclopedia of DNA Elements (ENCODE) data portal , 2019, Nucleic Acids Res..
[19] Chia-Lin Hsu,et al. Metabolite Transporters—The Gatekeepers for T Cell Metabolism , 2019, Immunometabolism.
[20] J. Tegnér,et al. Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma , 2019, Scientific Reports.
[21] Lu Zhang,et al. CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B , 2019, BMC Immunology.
[22] M. Kalady,et al. Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. , 2019, Cell metabolism.
[23] Hyewon Seo,et al. A rapid and sensitive liquid chromatography/tandem mass spectrometry assay for simultaneous quantitation of disopyramide and its major metabolite, mono-isopropyl-disopyramide, in rat plasma and its application to a pharmacokinetic study. , 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[24] G. Rabinovich,et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity , 2018, Nature.
[25] V. Boussiotis,et al. Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy , 2018, Front. Oncol..
[26] D. Munn,et al. Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death. , 2018, Cell metabolism.
[27] J. Borst,et al. CD4+ T cell help in cancer immunology and immunotherapy , 2018, Nature Reviews Immunology.
[28] R. Ke,et al. Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism , 2018, Cell biology international.
[29] Yi Fang,et al. Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation. , 2018, Cancer cell.
[30] A. Kimmelman,et al. Metabolic Interactions in the Tumor Microenvironment. , 2017, Trends in cell biology.
[31] R. Shaw,et al. AMPK: guardian of metabolism and mitochondrial homeostasis , 2017, Nature Reviews Molecular Cell Biology.
[32] S. Kaech,et al. Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries. , 2017, Current opinion in immunology.
[33] Huahao Shen,et al. Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis , 2017, Oncotarget.
[34] Takla Griss,et al. Serine Is an Essential Metabolite for Effector T Cell Expansion. , 2017, Cell metabolism.
[35] S. Woo,et al. API5 confers cancer stem cell-like properties through the FGF2-NANOG axis , 2017, Oncogenesis.
[36] B. Fazekas de St. Groth,et al. Tumour‐specific CD4 T cells eradicate melanoma via indirect recognition of tumour‐derived antigen , 2016, Immunology and cell biology.
[37] J. Boss,et al. Genetic and Epigenetic Regulation of PD-1 Expression , 2016, The Journal of Immunology.
[38] C. Rudd,et al. Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8+ Cytolytic T Cell Responses , 2016, Immunity.
[39] F. Polleux,et al. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress , 2016, Science.
[40] J. Michael Cherry,et al. ENCODE data at the ENCODE portal , 2015, Nucleic Acids Res..
[41] E. E. Vincent,et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. , 2015, Immunity.
[42] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[43] R. Ahmed,et al. STAT3, STAT4, NFATc1, and CTCF Regulate PD-1 through Multiple Novel Regulatory Regions in Murine T Cells , 2014, The Journal of Immunology.
[44] Russell G. Jones,et al. Amino acids fuel T cell-mediated inflammation. , 2014, Immunity.
[45] F. Brandizzi,et al. IRE1: ER stress sensor and cell fate executor. , 2013, Trends in cell biology.
[46] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[47] Linda V. Sinclair,et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation , 2013, Nature Immunology.
[48] David Haussler,et al. ENCODE Data in the UCSC Genome Browser: year 5 update , 2012, Nucleic Acids Res..
[49] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[50] J. Asara,et al. A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue , 2012, Nature Protocols.
[51] Yi Zhang,et al. The diverse functions of Dot1 and H3K79 methylation. , 2011, Genes & development.
[52] E. Wherry,et al. T-bet represses expression of PD-1 and sustains virus-specific CD8 T cell responses during chronic infection , 2011, Nature Immunology.
[53] J. Kirkwood,et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients , 2010, The Journal of experimental medicine.
[54] E. Gibney,et al. Epigenetics and gene expression , 2010, Heredity.
[55] S. Rosenberg,et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. , 2009, Blood.
[56] F. Martinon,et al. BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. , 2009, Molecular cell.
[57] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[58] A. T. Phillips. Desalting, Concentration, and Buffer Exchange by Dialysis and Ultrafiltration , 1995 .